Essential Insights That Every OB/GYN Should Know About HIV

There is great importance to discussing HIV with patients of child-bearing age, and discussing HIV treatment and potential perinatal transmission with patients living with HIV who are considering or have become pregnant, given that perinatal transmission may be vastly minimized. Obstetrician/Gynecologists (OB/GYNs) play a key role in reducing HIV perinatal transmission in the care and guidance they provide their patients, including those in underserved populations with increased risk of HIV. To assist these providers, the Department of Health and Human Services (DHHS) has provided guidelines on how to provide perinatal care to patients with or at risk of contracting HIV along with prophylaxis treatment available to infants. Providing education on these guidelines to OB/GYNs and other members of the multidisciplinary team caring for individuals with or at risk for HIV will help these individuals achieve and maintain viral suppression and greatly reduce the risk of perinatal transmission of HIV .

In this CME Outfitters Snack, expert faculty, including OB/GYNs, will address the educational needs of providers who care for patients with or at risk for HIV, explaining how to discuss HIV risk with patients and the latest guideline-based care and recommendations for those with or at risk of HIV considering pregnancy or who are currently pregnant.

At the conclusion of this activity, learners will be able to better:

• Integrate best practices for discussing HIV risk in your patients of child-bearing age
• Utilize DHHS guideline-based perinatal care in OB/GYN settings with all patients with HIV or at risk for HIV

Supported by an independent educational grant from Gilead Sciences, Inc.

OB/GYNs, physician associates (PAs), and nurse practitioners (NPs)

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. Relevant financial relationships exist between the following individuals and commercial interests:

Dr. Madison reports the following financial relationships:

Advisory Board and Consultant: GSK; ViiV Healthcare; and Sanofi

Stock Shareholder (ownership interest): Pills2Me and Wellness Equity Alliance

Dr. Scott reports the following financial relationships:

Advisory Board: ViiV Healthcare

Grants: Investigator-sponsored research award through ViiV Healthcare to support IMPAACT protocol 2040. Managed by IMPAACT network.

The following individuals have no financial relationships to disclose:

Rebecca Vargas-Jackson, MD (Peer Reviewer)
Joshua Caballero, PharmD, BCPP, FCCP (Peer Reviewer)
Davina (Dee Conner) Otalor (Patient/Patient Advocate/Planning Committee)
Mary Gleason, PhD, CHCP (Planning Committee)
Estelle Perera (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committe)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Call us at 877.CME.PROS (877.263.7767).

SN-255-031025-47